Finkernagel F

No ORCID on file · 2 papers in corpus · active 2016-2019

Study types

  • article 1
2019
Frontiers in oncology ·doi:10.3389/fonc.2019.01150

A central reason behind the poor clinical outcome of patients with high-grade serous carcinoma (HGSC) of the ovary is the difficulty in reliably detecting early occurrence or recurrence of this malignancy. Biomarkers that provide reliable d…

article 2016
Oncotarget ·doi:10.18632/oncotarget.12180

// Florian Finkernagel 1, * , Silke Reinartz 2, * , Sonja Lieber 1, * , Till Adhikary 1 , Annika Wortmann 1 , Nathalie Hoffmann 1 , Tim Bieringer 1 , Andrea Nist 3 , Thorsten Stiewe 3 , Julia M. Jansen 2 , Uwe Wagner 2 , Sabine Müller-Brüss…